Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Viral Hepat. 2014 Nov 24;22(8):675–681. doi: 10.1111/jvh.12368

Figure 3.

Figure 3

Complete viral suppression (CVS) rates at 6 months and 12 months in patients with a partial virological response to entecavir (ETV) on alternate therapy of tenofovir (TDF) monotherapy or ETV+TDF combination therapy stratified by duration of ETV monotherapy: ≤ 2 years vs. > 2 years